Drugs / human umbilical cord mesenchymal stem cell
last change Mar 2022 re-read 3 minutes ago

human umbilical cord mesenchymal stem cell

Cell therapy

Developed for
female infertility of uterine origin · lumbar disk disease · uterine disorder
Investigated by
Sclnow Biotechnology Co., Ltd.

Trials 3

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06503471 Dec 2026 → Jun 2027 female infertility of uterine origin Sclnow Biotechnology Co., Ltd. Suspended No outcome recorded Stop: Business
Phase 1 NCT04104412 Aug 2019 → Dec 2026 expected lumbar disk disease Sclnow Biotechnology Co., Ltd. Recruiting No outcome recorded
Phase 1 NCT03386708 Oct 2018 → Jun 2021 uterine disorder Sclnow Biotechnology Co., Ltd. Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as human umbilical cord mesenchymal stem cell ClinicalTrials.gov intervention name — accepted as the source's own label NCT03386708 ↗
2

NCT04104412 ↗

NCT06503471 ↗

Known as 19#iSCLife-UT “intrauterine injection with human umbilical cord mesenchymal stem cell (19#iSCLife®-UT); total 1 time” NCT06503471 ↗
Known as hUC-MSC “Human umbilical cord mesenchymal stem cells (hUC-MSC) (SCLnow 19#)” NCT03386708 ↗
Known as hUC-MSCs “SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility” NCT06503471 ↗
Known as human umbilical cord MSCs “All the patients were injected with human umbilical cord MSCs twice into the uterus.” PMID 35241151 ↗ Mar 2022
Known as SCLife-UT “SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility” NCT06503471 ↗
Known as SCLnow 19# “Human umbilical cord mesenchymal stem cells (hUC-MSC) (SCLnow 19#)” NCT03386708 ↗
Modality Cell therapy “Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy” NCT03386708 ↗
Route Other “intrauterine injection” NCT03386708 ↗